Cart
sales@molnova.com
KX1-004
CAS No. 518058-84-9
KX1-004( KX1004 | KX 1004 | KX1-004 )
Catalog No. M14808 CAS No. 518058-84-9
KX1-004 is a potent small molecule inhibitor of Src-PTK as a potential protective drug for NIHL.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 49 | In Stock |
|
| 5MG | 80 | In Stock |
|
| 10MG | 147 | In Stock |
|
| 25MG | 267 | In Stock |
|
| 50MG | 441 | In Stock |
|
| 100MG | 621 | In Stock |
|
| 500MG | 1305 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameKX1-004
-
NoteResearch use only, not for human use.
-
Brief DescriptionKX1-004 is a potent small molecule inhibitor of Src-PTK as a potential protective drug for NIHL.
-
DescriptionKX1-004 is a potent small molecule inhibitor of Src-PTK as a potential protective drug for NIHL.
-
In Vitro——
-
In VivoKX1-004 (30 μM) provides significant protection against noise-induced temporary threshold shift (TTS), permanent threshold shift (PTS) and outer hair cells (OHC) loss.KX1-004 (50 mg/kg) is effective against noise exposure.
-
SynonymsKX1004 | KX 1004 | KX1-004
-
PathwayTyrosine Kinase
-
TargetSrc
-
RecptorSrc-PTK
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number518058-84-9
-
Formula Weight284.29
-
Molecular FormulaC16H13FN2O2
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESO=C(C(N1)=CC2=C1C=CC(F)=C2)NCC3=CC=CC(O)=C3
-
Chemical Name5-fluoro-N-(3-hydroxybenzyl)-1H-indole-2-carboxamide.
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Harris KC, et al. Hear Res. 2005 Oct;208(1-2):14-25.
molnova catalog
related products
-
Caffeic acid-pYEEIE
Phosphopeptide ligand for the src SH2 domain (IC50 = 42 nM); displays 30-fold higher affinity than N-acetyl-O-phosphono-Tyr-Glu-Glu-Ile-Glu (Ac-pYEEIE,).
-
A 419259 trihydrochl...
A 419259 trihydrochloride is an Src family kinases inhibitor (IC50s: 9 nM, 3 nM and 3 nM for Src, Lck and Lyn).
-
eCF506
eCF506 is a potent and selective inhibitor of SRC (IC50 < 0.5 nM)eCF506, the first small molecule with subnanomolar IC50 for SRC that requires 3 orders of magnitude greater concentration to inhibit ABL.?
